Cilostazol inhibited insulin-induced and LXR-agonist-induced expression of SREBP-1c and its downstream targets, acetyl-CoA carboxylase and fatty acid synthase, in cultured hepatocytes.

Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.

Cilostazol may thus be particularly useful for treatment of patients with sick sinus syndrome associated with disorders that require antithromboembolic therapy.

While cilostazol has never been studied in this setting, there is at least some biologic plausibility for its use in this scenario.

In patients with femoropopliteal lesions, additional treatment with cilostazol after implantation of a drug-eluting stent is associated with significantly lower restenosis rates at 1 year ...

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease ...

The antiplatelet drug cilostazol (which prevents the blood from clotting) works as well as, and might be better than, aspirin in helping to prevent a secondary stroke in Asian patients, but with ...

Cilostazol given prior to a surgical procedure resulted in a safer transition off dual antiplatelet therapy (DAPT) by reducing the risk the risk of bleeding during the operation in patients with a ...

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events Triple antiplatelet therapy consisting of cilostazol added to clopidogrel and aspirin does not improve clinical outcomes in ...

Read the side effects of Cilostazol as described in the medical literature. In case of any doubt consult your doctor or pharmacist.